Wrong site, wrong procedure, wrong patient errors (WSPEs) have been an area of focus for regulatory and accrediting agencies, as well as for healthcare organizations, for a number of years. Beginning in 2007, The Centers for Medicare and Medicaid Services (CMS) stopped paying for any additional costs related to medical errors. In 2009, CMS ruled that hospitals would not be reimbursed for any costs tied to WSPE’s. These were also deemed to be “never events” by the National Quality Forum (NQF), as it was believed such occurrences should never happen and that these events reflected significant underlying patient safety issues.
Competency assessment begins at the time of the initial review of a candidate’s application and resume. It continues throughout the interview process and the validation of qualifications and credentials prior to hire. This is a joint responsibility of human resources and the organization’s hiring manager(s).
Download the whitepaper on Noninvasive Prenatal Genetic Testing by Alicia Bromfield, Esq. and Donald B. Lenderman
Download the whitepaper on Managing Disruptive Patient Behavior by Sandra Chellew, MBA, RN, CPHRM, CPHQ.
Download the whitepaper on Physician Credentialing and Risk Management by John E. Sanchez, MS, CPHRM.
Download the whitepaper by John E. Sanchez, Pendulum, LLC, regarding the importance of communication among caregivers.
Download the whitepaper on Evolving Healthcare Landscape Requires Insurance Solutions Not Just Insurance Products.
Download the whitepaper by IronHealth's Chief Claims Officer, Kristin McMahon, regarding the topic of the upward trend in the number of "related claims" also known as batch claims.
Download the whitepaper by IronHealth's Vice President & Product Manager, Theresa Galizia, and BLIS, Inc's President & CEO, Regi Schindler.
Download the whitepaper on Informed Consent by John Sanchez, MS, CPHRM.
Download the whitepaper coauthored by IronHealth's Alice Johansson and Jennifer C. Jordan, General Counsel, MEDVAL regarding the the Medicare Set- Aside liability dilemma.
The U.S. Supreme Court's June 2011 decision in Pliva v. Mensing2 represents a significant victory for generic pharmaceutical manufacturers.
Will Federal Preemption protect Generic Pharma from Plaintiff's state law claims of failure to warn?
For reducing the risk of carrier capsize.
Do they involve acts of professional liability or general negligence? It's not always clear.
The New Tidal Wave of Managed Care Litigation.
What impact will the recession have on the risk profile of U.S. hospitals?